Literature DB >> 1438775

Osgood-Schlatter lesion: fracture or tendinitis? Scintigraphic, CT, and MR imaging features.

Z S Rosenberg1, M Kawelblum, Y Y Cheung, J Beltran, W B Lehman, A D Grant.   

Abstract

To determine whether the Osgood-Schlatter lesion (OS) is produced by avulsion fracture or injury to the patellar tendon, all images obtained in 28 cases of OS in 20 patients (16 scintigrams, 34 computed tomographic [CT] scans, and 27 magnetic resonance [MR] images) were retrospectively analyzed. In 21 cases, imaging was performed before and after treatment; in 20 cases, relief from pain was complete at the time of repeat examination. In all patients (100%), abnormal size of the tendon, decreased attenuation, and increase in signal intensity were compatible with the CT and MR imaging appearance of tendinitis. Distended deep infrapatellar bursa was a frequent finding, particularly on MR studies. These abnormalities had partially disappeared at follow-up examination. An ossicle was seen in only nine of 28 cases (32%); in three of seven cases with follow-up, the ossicle remained nonunited to the tibial tuberosity on follow-up studies despite relief from symptoms. This implies that healing of fracture is not essential for relief from symptoms. These results strengthen the argument that in most cases of OS, insult to the tendon and associated soft tissues, rather than avulsion fracture, causes OS.

Entities:  

Mesh:

Year:  1992        PMID: 1438775     DOI: 10.1148/radiology.185.3.1438775

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  Deep and superficial infrapatellar bursae: cadaveric investigation of regional anatomy using magnetic resonance after ultrasound-guided bursography.

Authors:  Flavio C Viegas; Rodrigo O C Aguiar; Emerson Gasparetto; Edson Marchiori; Debbie J Trudell; Parviz Haghighi; Donald Resnick
Journal:  Skeletal Radiol       Date:  2006-05-20       Impact factor: 2.199

2.  Prevalence of lateral patellofemoral maltracking and associated complications in patients with Osgood Schlatter disease.

Authors:  Sarah I Kamel; Riti M Kanesa-Thasan; Jaydev K Dave; Adam C Zoga; William Morrison; Jeffrey Belair; Vishal Desai
Journal:  Skeletal Radiol       Date:  2021-01-06       Impact factor: 2.199

Review 3.  MRI of anterior knee pain.

Authors:  Mohammad Samim; Edward Smitaman; David Lawrence; Hicham Moukaddam
Journal:  Skeletal Radiol       Date:  2014-01-29       Impact factor: 2.199

4.  [Clinical examination, imaging and therapy of Osgood-Schlatter's disease].

Authors:  H Gaulrapp
Journal:  Orthopade       Date:  2016-03       Impact factor: 1.087

Review 5.  MRI of the knee: key points in the pediatric population.

Authors:  Peter J Strouse
Journal:  Pediatr Radiol       Date:  2010-04

Review 6.  Injuries of the adolescent girl athlete: a review of imaging findings.

Authors:  Kimberly Shampain; Kara Gaetke-Udager; Jessica R Leschied; Nathaniel B Meyer; Matthew R Hammer; Keri L Denay; Corrie M Yablon
Journal:  Skeletal Radiol       Date:  2018-08-20       Impact factor: 2.199

7.  Infrapatellar bursitis in children with juvenile idiopathic arthritis: a case series.

Authors:  Jubran T Alqanatish; Ross E Petty; Kristin M Houghton; Jaime Guzman; Lori B Tucker; David A Cabral; Robyn A Cairns
Journal:  Clin Rheumatol       Date:  2010-11-19       Impact factor: 2.980

8.  Clinics in diagnostic imaging (185).

Authors:  Ying Xin Candice Leong; Poh Lye Paul See
Journal:  Singapore Med J       Date:  2018-04       Impact factor: 1.858

Review 9.  The MRI appearance of cystic lesions around the knee.

Authors:  Catherine L McCarthy; Eugene G McNally
Journal:  Skeletal Radiol       Date:  2004-02-27       Impact factor: 2.199

10.  Doppler ultrasound and tibial tuberosity maturation status predicts pain in adolescent male athletes with Osgood-Schlatter's disease: a case series with comparison group and clinical interpretation.

Authors:  Matthieu Sailly; Rod Whiteley; Amanda Johnson
Journal:  Br J Sports Med       Date:  2012-09-05       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.